Explore more publications!

Harrisburg Daily Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.

Press releases published on January 23, 2026

Why Pittsburgh’s Community Continues to Shape Its Food Entrepreneurs
Altek Business Systems, Inc. Issues Security Guidance on Addressing 'Last Mile' Vulnerabilities in Print Devices
Cordisco & Saile Announces Addition of Three Attorneys, Expanding Injury Law Services Across Eastern Pennsylvania
RTW Foundation donates $8 million to reimagine physician training in Penn’s Perelman School of Medicine
CubeSmart Announces the Date of Its Fourth Quarter 2025 Earnings Release and Conference Call
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Regional Law Firms Are Often the First to See Emerging Safety Risks, Long Before They Become National Issues, Says Tim George From Purchase, George & Murphey, P.C.
DEADLINE ALERT for VRNS, ARDT, CRWV, BBWI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Toll Brothers Announces New Luxury Home Collection Coming Soon to Milton, Georgia
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
Laurel Health Centers Data Breach Claims Investigated by Lynch Carpenter
HHM Hotels Adds Growth-Oriented Senior Executives
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Berger Montague PC Investigating Claims on Behalf of BellRing Brands, Inc. (NYSE: BRBR) Investors After Class Action Filing
DEADLINE APPROACHING: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Inquire About a Securities Fraud Class Action by February 9, 2026
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Essent Group Ltd. Schedules Fourth Quarter Earnings Conference Call for February 13, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions